The FDA approved the first triple-combination gel, IDP-126, for acne treatment, and also recommended modifications to the iPledge REMS for isotretinoin users. The most read Healio acne story this year was the FDA’s approval of IDP-126, followed by a study finding that IDP-126 improves patients’ quality of life compared to vehicle. Other important updates in 2023 include the efficacy of M-PDT and clascoterone cream, as well as an update to the FDA’s iPledge recommendations. This year’s top five popular Healio acne stories include the FDA’s approval of IDP-126 and its benefits, as well as the effectiveness and long-term safety of clascoterone cream.
Source link
Approval of triple-combination gel tops most read Healio acne news of 2023
